Over the past four decades after World War II aa great deal of data and clinical experiences have been accumulated relating to the diagnosis and surgical treatment of cardiovascular disease in Korea. Clinical data after the first open heart
surgery
on
August 7,1059 up to 1984 revealed the total number of cardiovascular surgery in Korea as 13,100 cases performed in 22 institutes with overall hospital mortality of 7.7%(Cardiovascular Surgery in Korea 1985).
Publishing committee of the Korea Thoracic and cardiovascular surgical Society collected the data of cardiovascular surgical cases in Korea again in between 1985 and 1990 from 38 institutes out of total 42 institutes of open heart centers in
Korea.
@ES The results are:
@EN 1. The survey reply ratio was 90.5%(38 out of 42 institutes).
2. Of the total 30,601 cases of cardiovascular surgery reported from 38 institutes 1,402 cases were failed as hospital mortality of 4.7%(4.5% ofthe 21,761 operations for congenital, and 5.2% of the 8,300 operations for acquired heart diseases).
3. Out of the total congonital cases, 17,303 cases were acyantio group with an operative mortality as 2.05, and 4,458 cases were cyanotic group with a hospital mortality as 14.1%. The incidence of corrective operations for complex congenital
cardiac
cardiac anomalies were increasing recently with decreasion age group.
3. During the year in 1990, 38 institutes performed 5,427 cardiovascular surgery with a hospital mortality of 3.4%.
4. Of the total cummulative 6,458 cases for cardiac valve surgery more than 90% cases were put to prosthetic valve replacement with hospital mortality as 4.8%. And the incidence of re-do valve surgery was increasing recently as 13.1% in 1990.
5. coronary artery bypass graft was increasing recently with 7.9% of hospital mortality in total 440 cases. Intracardiac operation for intractable arrhythmia was started since 1987 as 49 cases in total. Experiences on VAD and ECMO were also
reported
sporadically in recent year.
6. Home made oxygentor (OXYREX) is now in clinical use, and under animal experiment for clinical trial in near future.
|